Reclast
Links shared publicly online about this topic
Reclast approved for biennial dosing regimen to prevent female osteoporosis - MPR
empr.com — “The FDA has approved Reclast (zoledronic acid, from Novartis) injection for the prevention of osteoporosis in women for two years with a single dose.” View full resource at empr.com
Most Recently Shared on June 2, 2009 at 3:08 pm By:
MPR News: Reclast approved for biennial dosing regimen to prevent female osteoporosis: The FDA has appr.. http://tinyurl.com/lk629z
FDA approves Reclast (zoledronic acid) for osteoporosis in postmenopausal women
news-medical.net — “Reclast (zoledronic acid) Injection has been approved by the US Food and Drug Administration (FDA) as the first and only therapy to prevent postmenopausal osteoporosis for two years with a single dose. Reclast is already approved as a once-yearly infusion for the treatment of postmenopausal osteoporosis.” View full resource at news-medical.net
Most Recently Shared on June 1, 2009 at 2:02 pm By:
Osteoporosis News: FDA approves Reclast (zoledronic acid) for osteoporosis in postmenopausal w.. http://tinyurl.com/ktja8m
Fosomax, Boniva, Reclast, Actonel May Cause Bone Fractures
herbalmd.com — “Fosomax, Boniva, Reclast, Actonel are supposed to help you from getting bone fractures as you get older. We now have evidence that they cause bone breaks.” View full resource at herbalmd.com
Most Recently Shared on July 28, 2011 at 6:28 am By:
Ray Mcnamee CAM and Health Communicator
These Drugs Poison Your Bones http://tinyurl.com/3of6uqt
FDA Alert: Reclast (zoledronic acid): Drug Safety Communication - New Contraindication and Updated Warning on Kidney Impairment
drugs.com — “FDA Alert: Reclast (zoledronic acid): Drug Safety Communication - New Contraindication and Updated Warning on Kidney Impairment” View full resource at drugs.com
Most Recently Shared on September 2, 2011 at 7:47 pm By:
FDA Alert - Reclast (zoledronic acid): New Contraindication and Updated Warning on Kidney Impairment - http://t.co/kydCwth
FDA: Osteoporosis Drug Reclast Ups Kidney Failure Risk
webmd.com — “The FDA warns that the osteoporosis drug Reclast (zoledronic acid) raises the risk of kidney failure.” View full resource at webmd.com
Most Recently Shared on September 2, 2011 at 6:00 pm By:
FDA: Osteoporosis Drug Reclast Raises Kidney Failure Risk http://t.co/5OhyTtn
FDA Alert: Reclast (zoledronic acid): Drug Safety Communication - New Contraindication and Updated Warning on Kidney Impairment
drugs.com — “FDA Alert: Reclast (zoledronic acid): Drug Safety Communication - New Contraindication and Updated Warning on Kidney Impairment” View full resource at drugs.com
Most Recently Shared on September 1, 2011 at 9:04 pm By:
Drugs and Devices OW OW Health
Reclast (zoledronic acid): Drug Safety Communication - New Contraindication and Updated Warning on Kidney I... http://t.co/5XKQyOW #FDA
MD Consult: Reclast now approved to prevent as well as treat osteoporosis: FDA Approval
mdconsult.com — “MD Consult: Reclast now approved to prevent as well as treat osteoporosis: FDA Approval” View full resource at mdconsult.com
Most Recently Shared on June 4, 2009 at 3:20 pm By:
MD Consult Health Site and Medical Publisher
New FDA Approval! Reclast now approved to prevent, as well as treat osteoporosis. http://tinyurl.com/rxspbh
MediGuard.org - Reclast | Drug safety information | Monitoring more than 510 patients
mediguard.org — “MediGuard.org - Reclast | Drug safety information | Monitoring more than 510 patients” View full resource at mediguard.org
Most Recently Shared on February 24, 2011 at 10:17 pm By:
MediGuard.org Health Organization
76% of patients taking #reclast use it for Osteoporosis ... http://tinyurl.com/4sed7p9
Letter on Failure to Warn U.S. Doctors and Patients of Zoledronic Acid (Reclast) Dangers
citizen.org — “Letter on Failure to Warn U.S. Doctors and Patients of Zoledronic Acid (Reclast) Dangers” View full resource at citizen.org
Most Recently Shared on March 14, 2011 at 5:18 pm By:
Sidney Wolfe, MD Doctor, Internist, and Physician
Letter on Failure to Warn U.S. #Doctors of Zoledronic Acid (Reclast) Dangers http://bit.ly/hxbojH
SAFETY ALERT: Reclast Labeling Updated to Include New Contraindication and Updated Warnings - MPR
empr.com — “The FDA has notified healthcare professionals and patients of an update to the labeling for Reclast (zoledronic acid; Novartis) regarding the risk of kidney failure.” View full resource at empr.com
Most Recently Shared on September 2, 2011 at 1:20 am By:
SAFETY ALERT: Reclast Labeling Updated to Include New Contraindication and Updated Warnings http://ow.ly/6jh1e #osteoporosis
Novartis Once-Yearly Reclast Preserves Bone Mass and Fracture Protection in Postmenopausal Osteoporosis
disabled-world.com — “Long-term data show novartis once-yearly reclast preserves bone mass and provides fracture protection in postmenopausal osteoporosis” View full resource at disabled-world.com
Most Recently Shared on October 17, 2010 at 8:56 pm By:
Disabled World Health Advocate and Health News
Novartis Once-Yearly Reclast Preserves Bone Mass and Fracture Protection in Postmenopausal Osteoporosis http://ff.im/-scR8n
FDA approves Reclast to prevent osteoporosis in postmenopausal women with convenient less frequent dosing
novartis.com — “Basel, June 1, 2009 - Reclast (zoledronic acid 5 mg) Injection[*] has been approved by the US Food and Drug Administration (FDA) as the first and only therapy to prevent postmenopausal osteoporosis for two years with a single dose[1]. Reclast, or Aclasta as it is known outside the US, is already approved in more than 80 countries including the US and EU as a once-yearly infusion for the treatment of postmenopausal osteoporosis[1],[4].” View full resource at novartis.com
Most Recently Shared on June 1, 2009 at 5:36 am By:
FDA approves Reclast® to prevent osteoporosis in postmenopausal women with convenient less frequent dosing: http://twurl.nl/po8fan
Symposier - Femur Fracture Risk with Osteoporosis Drugs: Fosamax, Actonel, Boniva, Atelvia, Reclast
symposier.com — “Uploaded and shared in Youtube by: USFoodandDrugAdmin --" bisphosphonates to treat osteoporosis. These drugs include Fosamax (alendronate sodium), Actonel (risedronate sodium), Boniva (ibandronate sodium), Atelvia (risedronate sodium), Reclast (zoledronic acid), and their generic equivalents. The femur fractures seen with bisphosphonates have been subtrochanteric and diaphyseal, which are uncommon --- accounting for less than one percent of the hip and femur fractures that occur in the populatio” View full resource at symposier.com
Most Recently Shared on February 9, 2011 at 1:17 am By:
Symposier Endocrino Health Site
Femur Fracture Risk with Osteoporosis Drugs: Fosamax, Actonel, Boniva, Atelvia, Reclast. http://bit.ly/fVvcGI
Reclast (zoledronic acid): Drug Safety Communication - New Contraindication and Updated Warning on Kidney Impairment - Drugs.com MedNews
drugs.com — “AUDIENCE Endocrinology, Pharmacy, Patient ISSUE FDA notified healthcare professionals and patients of an update to the drug label for Reclast (zoledronic acid)” View full resource at drugs.com
Most Recently Shared on September 2, 2011 at 1:16 pm By:
Drugs and Devices OW OW Health
Reclast (zoledronic acid): Drug Safety Communication - New Contraindication and Updated Warning on Kidney ... http://t.co/ROMQGcD #drug
Medical News: Reclast Gets FDA Kidney Failure Warning - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “The osteoporosis drug zoledronic acid (Reclast) should not be used in patients with significant renal impairment, and physicians should screen patients for kidney dysfunction before starting them on t” View full resource at medpagetoday.com
Most Recently Shared on September 1, 2011 at 7:40 pm By:
Reclast Gets FDA Kidney Failure Warning http://t.co/tR7kyDv
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
News-Medical.Net
Stay up to date with the latest Osteoporosis news and research via News-Medical.Net
-
Ray Mcnamee
HerbalMD provides our readers with the most accurate and timely scientific based information on vitamins, minerals and herbal supplements.
Advertisement
